Impact of High Flow Nasal Cannula Therapy on Oral Feeding in Very Low Birth Weight Infants with Chronic Lung Disease

DOI IR Web Site Web Site PubMed 23 References
  • SHIMIZU Daisuke
    Center of Maternal, Fetal and Neonatal Medicine, Hospital of the University of Occupational and Environmental Health, Japan.
  • ARAKI Shunsuke
    Center of Maternal, Fetal and Neonatal Medicine, Hospital of the University of Occupational and Environmental Health, Japan.
  • KAWAMURA Masaru
    Center of Maternal, Fetal and Neonatal Medicine, Hospital of the University of Occupational and Environmental Health, Japan.
  • KUWAMURA Mami
    Center of Maternal, Fetal and Neonatal Medicine, Hospital of the University of Occupational and Environmental Health, Japan.
  • SUGA Shutaro
    Center of Maternal, Fetal and Neonatal Medicine, Hospital of the University of Occupational and Environmental Health, Japan.
  • MIYAKE Fuyu
    Center of Maternal, Fetal and Neonatal Medicine, Hospital of the University of Occupational and Environmental Health, Japan.
  • ICHIKAWA Shun
    Center of Maternal, Fetal and Neonatal Medicine, Hospital of the University of Occupational and Environmental Health, Japan.
  • KINJO Tadamune
    Department of Neonatology, Fukuoka Childrenʼs Hospital
  • KUSUHARA Koichi
    Center of Maternal, Fetal and Neonatal Medicine, Hospital of the University of Occupational and Environmental Health, Japan.

Bibliographic Information

Other Title
  • High Flow Nasal Cannula療法が慢性肺疾患の極低出生体重児の経口哺乳確立に与える影響

Search this article

Abstract

Previous studies on high-flow nasal cannula (HFNC) in very-low-birth-weight infants (VLBWIs) focused on comparing HFNC with nasal continuous positive airway pressure (nCPAP) to determine the usefulness of HFNC as a backup in the case of extubation failure and nasal trauma; however, the studies did not consider oral feeding. This retrospective case-control study aimed at elucidating whether HFNC could prevent the delay in feeding and achievement of full oral feeding in VLBWIs with chronic lung disease (CLD). Forty five VLBWIs were enrolled in this study: an HFNC group (<i>n</i> = 11) that was supported by HFNC at oral feeding initiation, and a non-HFNC group (n = 34) that could start oral feeding without HFNC. The gestational age and birth weight of the HFNC group were lower than those in the non-HFNC group. The median duration of exposure to oxygen and neonatal intensive care unit stay were comparable in both groups. The timings of oral feeding initiation and full oral feeding achievement in both groups were not significantly different: 35.3 (33.0 – 38.1) vs. 35.5 (33.7 – 42.4) weeks (P = 0.91) for the HFNC and 38.6 (34.4 – 42.3) vs. 36.7 (34.6 – 44.4) weeks postmenstrual age (P = 0.29) for the non-HFNC. Clinically significant aspiration pneumonia during the period of oral feeding was not observed in the HFNC group. Respiratory support by HFNC in VLBWIs with CLD might prevent oral feeding delay. Initiation of oral feeding of VLBWIs on HFNC might be safe and might accelerate the achievement of oral feeding milestones.

Journal

  • Journal of UOEH

    Journal of UOEH 41 (2), 131-138, 2019-06-01

    The University of Occupational and Environmental Health, Japan

References(23)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top